ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies
Two Spires was responsible for successfully conducting market research on behalf of ICON in technology trends in the use of electronic patient recorded outcomes (ePRO) and formulating a strategy whitepaper that examined likely key developments in this area of the pharma sector



